Medicare’s New AI-First Payment Model Could Reshape the Future of Healthcare
The future of healthcare may no longer revolve around hospital visits and paperwork alone. A major shift is quietly unfolding inside the U.S. healthcare system, and it could become one of the most important AI adoption stories of the decade.
The Centers for Medicare & Medicaid Services (CMS) has launched a new long-term initiative called ACCESS — short for Advancing Chronic Care with Effective, Scalable Solutions — designed to test how artificial intelligence and outcome-driven healthcare models can improve treatment for millions of patients with chronic illnesses.
The program represents a fundamental transformation in how healthcare services are funded. Instead of reimbursing providers based on the number of appointments, check-ins, or clinician hours, ACCESS rewards measurable patient outcomes such as improved blood pressure, reduced pain, better mental health management, and fewer emergency hospital visits.
This new structure is especially important because it finally creates a payment system for AI-powered healthcare support. Under traditional Medicare models, there was little financial incentive for technologies that monitor patients remotely, coordinate medication schedules, perform wellness check-ins, or assist vulnerable individuals outside clinical settings.
Now, AI systems capable of handling these tasks could become financially sustainable at federal scale.
One of the companies selected for the first ACCESS cohort is Pair Team, a healthcare startup focused on serving patients dealing with chronic disease alongside social challenges such as housing instability, food insecurity, and lack of transportation.
Founded in 2019 by Neil Batlivala, Pair Team built its care model around the idea that health outcomes cannot improve without addressing the broader realities of a patient’s life. The company combines medical support, behavioral care, and social assistance into a single coordinated system.
Today, Pair Team reportedly employs hundreds of healthcare professionals and operates one of California’s largest community health workforces. The company has also attracted funding from major investors and claims to generate annual revenue exceeding nine figures.
What makes the company particularly notable in the AI conversation is its recent deployment of an AI voice assistant called Flora. The AI agent acts as a 24/7 patient-facing support system capable of handling intake conversations, wellness monitoring, appointment coordination, and patient engagement between medical visits.
According to company executives, the system is already changing how care is delivered. In some cases, vulnerable patients spend extended periods speaking with the AI assistant about mental health struggles, housing challenges, and chronic illnesses — interactions that may never happen in traditional healthcare environments due to limited staffing and costs.
The ACCESS program appears intentionally designed to encourage these types of AI-first healthcare operations. The initiative spans a wide range of participants, including AI healthcare startups, wearable technology companies, virtual therapy providers, and digital health platforms.
Industry observers believe the payment structure could accelerate a major shift in healthcare economics. AI systems can provide continuous monitoring and engagement at lower operational costs compared to large human care teams. For healthcare organizations managing thousands of patients, automation may significantly reduce emergency room visits, hospital admissions, and long-term treatment expenses.
However, the transformation also raises serious concerns.
Healthcare AI systems process highly sensitive patient information, including medical histories, mental health discussions, housing data, and personal conversations. Privacy advocates warn that expanding AI infrastructure within federal healthcare systems could increase cybersecurity risks and data exposure concerns.
Financial sustainability is another challenge. Previous CMS innovation initiatives have delivered mixed results, with some programs increasing overall federal healthcare spending instead of reducing it. Analysts note that the ACCESS model may only work efficiently for organizations that heavily automate patient interactions using AI tools.
Still, investor enthusiasm around AI healthcare continues growing rapidly. Digital health funding has rebounded strongly in 2026, with AI-focused startups attracting a significant share of investment capital. Many investors now view healthcare as one of the largest long-term opportunities for applied artificial intelligence.
The broader significance of ACCESS extends far beyond healthcare startups alone. It demonstrates how governments are beginning to redesign regulations and payment systems specifically around AI capabilities. Rather than treating artificial intelligence as an optional software layer, policymakers are building infrastructure that assumes AI will become a core part of future public services.
If successful, ACCESS could become a blueprint for AI-driven healthcare systems worldwide — where intelligent software manages routine care, monitors patient well-being continuously, and allows human clinicians to focus on complex medical decisions and high-touch patient relationships.
The program officially launches in July and may ultimately determine whether AI can move from experimental healthcare technology to a mainstream component of national medical infrastructure.